News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
173 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (66)
3 (2)
4 (14)
5 (297)
6 (263)
7 (227)
8 (79)
9 (6)
10 (9)
11 (173)
12 (214)
13 (136)
14 (156)
15 (56)
17 (3)
18 (145)
19 (230)
20 (173)
21 (177)
22 (79)
23 (2)
25 (134)
26 (227)
27 (192)
28 (175)
29 (97)
30 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
25
26
27
28
29
30
Policy
Lilly Sues Pharmacies, Spas and Wellness Centers Over Unapproved Mounjaro Copycats
Eli Lilly has filed lawsuits in several states seeking to prevent unauthorized selling of products that claim to contain tirzepatide, the active ingredient in its blockbuster type 2 diabetes drug Mounjaro.
September 20, 2023
·
2 min read
·
Matt Olszewski
Policy
How Will AI in Hiring Be Regulated?
With 88% of life sciences organizations using or planning to use AI in recruitment and/or hiring, AI regulation is a priority for the industry.
September 20, 2023
·
6 min read
·
Lori Ellis
Policy
FDA Rejects ARS’ Epinephrine Nasal Spray Despite Adcomm Support
Though it received backing from the Pulmonary-Allergy Drugs Advisory Committee in May, the FDA on Tuesday rejected ARS Pharmaceuticals’ neffy as a nasal spray for allergic reactions.
September 20, 2023
·
2 min read
·
Tristan Manalac
Job Trends
New Training Models Address Workforce Gap in Biopharma Manufacturing
Mock facilities can shorten the time it takes to bring new employees up to speed on processes and logistics, as well as allow companies to recruit individuals with limited experience.
September 20, 2023
·
4 min read
·
Jennifer Markarian
Employer Resources
Report: Recruiting with AI: Trends and Challenges in Life Sciences
BioSpace surveyed life sciences employers to understand attitudes and current trends on AI usage in recruiting. This report explores the benefits of using AI tools in recruitment and provides practical recommendations for HR and talent acquisition professionals to leverage AI effectively. Concurrently, this report highlights the challenges and risks of using these tools without critical thought and intention.
September 20, 2023
·
1 min read
·
BioSpace Insights
Business
Taysha Drops Gene Therapy Candidate as FDA Again Calls for Study Changes
The company has dropped its gene therapy candidate TSHA-120 for giant axonal neuropathy after the FDA reiterated the need for a randomized, double-blind, placebo-controlled trial.
September 20, 2023
·
2 min read
·
Connor Lynch
ReCode Raises $260M in Series B Financing to Advance Lead Programs
Bringing in an additional $50 million in a Series B extension, ReCode Therapeutics’ total haul for the funding round totaled $260 million, which it will use to further its experimental mRNA therapies.
September 20, 2023
·
2 min read
·
Tristan Manalac
Business
Genentech, PeptiDream Ink Potential $1B Radiopharma Deal
The Japanese biopharma will receive $40 million upfront from Genetech for R&D of its macrocyclic peptide-radioisotope drug conjugates, with another $1 billion on the line in milestone payments.
September 20, 2023
·
1 min read
·
Kate Goodwin
Drug Development
10 Promising Therapies for Hard-to-Treat Cancers
In honor of World Cancer Research Day, BioSpace takes a deep dive into 10 therapeutic candidates with the potential to change the treatment landscape in lung, breast, colorectal cancer and more.
September 20, 2023
·
8 min read
·
Hayley Shasteen
Business
Fresh Tracks, Histogen to Shutter Businesses in Absence of Viable Options
The companies have announced the impending closures of their respective businesses. Histogen will lay off most of its employees by the end of September. Fresh Tracks will do so by early October.
September 20, 2023
·
2 min read
·
Tristan Manalac
1 of 18
Next